Catalyst Pharmaceuticals (CPRX) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -0.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.80% |
| Dec 31, 2025 | -36.63% |
| Sep 30, 2025 | -55.33% |
| Jun 30, 2025 | 11.15% |
| Mar 31, 2025 | 89.25% |
| Dec 31, 2024 | 27.42% |
| Sep 30, 2024 | 61.13% |
| Jun 30, 2024 | 108.51% |
| Mar 31, 2024 | 164.47% |
| Dec 31, 2023 | 38.62% |
| Sep 30, 2023 | 9.11% |
| Jun 30, 2023 | 17.42% |
| Mar 31, 2023 | 41.50% |
| Dec 31, 2022 | 109.44% |
| Sep 30, 2022 | 90.86% |
| Jun 30, 2022 | 67.10% |
| Mar 31, 2022 | 192.04% |
| Dec 31, 2021 | 46.01% |
| Sep 30, 2021 | 88.97% |
| Jun 30, 2021 | 18.16% |
| Mar 31, 2021 | -59.75% |
| Dec 31, 2020 | 6.61% |
| Sep 30, 2020 | -29.59% |
| Jun 30, 2020 | -5.66% |
| Mar 31, 2020 | 189.91% |
| Dec 31, 2019 | 246.19% |
| Sep 30, 2019 | 333.12% |
| Jun 30, 2019 | 394.54% |
| Mar 31, 2019 | -31.91% |
| Dec 31, 2018 | -108.65% |
| Sep 30, 2018 | -164.97% |
| Jun 30, 2018 | -49.13% |
| Mar 31, 2018 | -56.78% |
| Dec 31, 2017 | 8.80% |
| Sep 30, 2017 | 19.68% |
| Jun 30, 2017 | 26.30% |
| Mar 31, 2017 | 34.59% |
| Dec 31, 2016 | 4.59% |
| Sep 30, 2016 | 38.82% |
| Jun 30, 2016 | -2.28% |
| Mar 31, 2016 | -55.94% |
| Dec 31, 2015 | -15.96% |
| Sep 30, 2015 | -50.24% |
| Jun 30, 2015 | -41.71% |
| Mar 31, 2015 | -55.71% |
| Dec 31, 2014 | 3.30% |
| Sep 30, 2014 | -111.76% |
| Jun 30, 2014 | -65.37% |
| Mar 31, 2014 | -8.13% |
| Dec 31, 2013 | -151.95% |
| Sep 30, 2013 | -52.96% |
| Jun 30, 2013 | -58.10% |
| Mar 31, 2013 | -72.91% |
| Dec 31, 2012 | -13.84% |
| Sep 30, 2012 | 12.11% |
| Jun 30, 2012 | 21.66% |
| Mar 31, 2012 | -57.17% |
| Dec 31, 2011 | -87.22% |
| Sep 30, 2011 | -53.26% |